1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Gene Expression Analysis Market by Technology , Consumables , Services & Applications - Global Forecasts to 2020

The global gene expression analysis market is projected to grow at a CAGR of 9.3% from 2015 to 2020 to reach 5.30 billion by 2020.

The global gene expression analysis market is expected to witness moderate growth in the coming years. The availability of funding, growth in the number of cancer patients, strong focus on research, and the decreasing cost of sequencing are the major factors driving the growth of the gene expression analysis markets. The increasing focus on precision medicines and adoption amongst emerging countries provides attractive/lucrative growth opportunities for the market. However, the high cost of certain instruments poses as a market restraint while the currency devaluation in developing countries poses as challenge for the market.

In 2015, the services segment is expected to grow at the fastest CAGR from 2015 to 2020 in the global gene expression analysis market, by type. The insights obtained through gene expression profiling play a vital role in the advancement of disease diagnosis, drug discovery, and precision medicine. This is expected to boost the demand for gene expression profiling services in the coming years.

In 2015, North America is expected to account for the largest share of the global gene expression analysis market, followed by Europe, Asia, and the Rest of the World (RoW). Asia-Pacific is expected to be the fastest growing regional segment from 2015 to 2020. North America’s large share is attributed to development of gene therapy in the U.S., and focus on gene expression studies to improve the quality of patient care. Increasing research activities on agriculture, government intervention to improve healthcare, and rising popularity of gene expression tests are the factors expected to augment growth in the Asia-Pacific region.

The market witnesses high competitive intensity, as there are few large players and several small players. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.
Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), and PerkinElmer (U.S.). are few of the major players in the global gene expression analysis market.


Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned four strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios of top players in the gene expression analysis market. The report analyzes the gene expression analysis market, by product, services, and by application
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the gene expression analysis market
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis markets across regions
- Competitive Assessment: In-depth assessment of market shares, and strategies of the leading players in the gene expression analysis market

Table Of Contents

Gene Expression Analysis Market by Technology , Consumables , Services and Applications - Global Forecasts to 2020
TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 PACKAGE SIZE 19
1.6 LIMITATIONS 19
1.7 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH METHODOLOGY STEPS 21
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 22
2.2.1 SECONDARY RESEARCH 22
2.3 KEY DATA FROM SECONDARY SOURCES 22
2.3.1 PRIMARY RESEARCH 23
2.3.2 KEY INDUSTRY INSIGHTS 24
2.4 KEY DATA FROM PRIMARY SOURCES 25
2.5 KEY INSIGHTS FROM PRIMARY SOURCES 26
2.6 MARKET SIZE ESTIMATION METHODOLOGY 26
2.7 MARKET FORECAST METHODOLOGY 28
2.8 MARKET DATA VALIDATION AND TRIANGULATION 29
2.9 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
3.1 INTRODUCTION 30
4 PREMIUM INSIGHTS 35
4.1 GLOBAL GENE EXPRESSION ANALYSIS MARKET OVERVIEW 35
4.2 GEOGRAPHIC ANALYSIS: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT 36
4.3 GEOGRAPHICAL SNAPSHOT OF THE GENE EXPRESSION ANALYSIS MARKET 37
4.4 GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2015 VS. 2020 38

5 INDUSTRY INSIGHTS 39
5.1 VALUE CHAIN ANALYSIS 39
5.2 PORTER'S FIVE FORCES ANALYSIS 40
5.2.1 THREAT OF NEW ENTRANTS 40
5.2.2 THREAT OF SUBSTITUTES 40
5.2.3 BARGAINING POWER OF BUYERS 41
5.2.4 BARGAINING POWER OF SUPPLIERS 41
5.2.5 COMPETITIVE RIVALRY AMONG EXISTING FIRMS 41
5.3 INDUSTRY VIEWS/INSIGHTS/ INDUSTRY TALKS 41
6 MARKET OVERVIEW 42
6.1 INTRODUCTION 43
6.2 MARKET SEGMENTATION 43
6.3 MARKET DYNAMICS 44
6.3.1 DRIVERS 44
6.3.1.1 Decreasing cost of sequencing 44
6.3.1.2 Growth in the number of cancer patients 45
6.3.1.3 Availability of government funding 45
6.3.1.4 Use of microarray technology to aid gene expression studies 45
6.3.1.5 SBS technology to aid more detailed cancer studies 46
6.3.1.6 Availability of gene expression databases 46
6.3.2 RESTRAINTS 47
6.3.2.1 High cost of instruments 47
6.3.2.2 Shortage of trained professionals 47
6.3.3 OPPORTUNITIES 48
6.3.3.1 Emerging countries to provide growth opportunities 48
6.3.3.1.1 Collaborative efforts in China aimed at improving the quality of healthcare 48
6.3.3.1.2 Strong focus on the biotechnology sector in India 48
6.3.3.1.3 Government funding for research in Brazil 49
6.3.3.2 Growing government focus on personalized medicine 49
6.3.4 CHALLENGE 50
6.3.4.1.1 Currency Devaluation 50
7 GENE EXPRESSION ANALYSIS MARKET, BY CONSUMABLES 51
7.1 INTRODUCTION 52
7.2 REAGENTS 55
7.3 DNA CHIPS 55

8 GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TECHNOLOGY 57
8.1 INTRODUCTION 58
8.2 POLYMERASE CHAIN REACTION (PCR) 59
8.3 NEXT-GENERATION SEQUENCING (NGS) 60
8.3.1 COST AND SPEED OF NGS 61
8.3.2 SUBSTITUTION OF MICROARRAY TECHNOLOGY BY NGS 61
8.3.3 RESEARCH LABORATORIES AND ACADEMICIANS PROMOTING NGS 62
8.3.4 GLOBAL ALLIANCES AMONG LEADING RESEARCH INSTITUTES TO ASSIST DRUG DISCOVERY AND INCREASE THE DEMAND FOR NGS 62
8.4 DNA MICROARRAY 63
8.5 OTHERS 63
8.5.1 SERIAL ANALYSIS OF GENE EXPRESSION 63
8.5.2 NORTHERN BLOTTING 64
9 GENE EXPRESSION ANALYSIS MARKET, BY SERVICE 65
9.1 INTRODUCTION 66
9.2 GENE EXPRESSION PROFILING SERVICES 68
9.2.1 SEQUENCING SERVICES 70
9.2.2 OTHER SERVICES 70
9.3 BIOINFORMATICS SOLUTIONS 71
10 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATIONS 72
10.1 INTRODUCTION 73
10.2 RESEARCH 74
10.3 DRUG DISCOVERY 75
10.4 DIAGNOSTICS 76
10.5 OTHER APPLICATIONS 77
11 GENE EXPRESSION MARKET, BY REGION 78
11.1 INTRODUCTION 79
11.2 NORTH AMERICA 80
11.2.1 U.S. 82
11.2.1.1 Development of gene therapy in the U.S. 82
11.2.1.2 Focus on gene expression studies to improve quality of patient care 83
11.2.1.3 Precision Medicine Initiative 83
11.2.1.4 Government Funding 83
11.2.2 CANADA 85
11.2.2.1 Gene expression profiling tests in Canada 85
11.2.2.2 Government Initiatives 85
11.2.2.3 Government funding for NGS 86

11.3 EUROPE 88
11.3.1 U.K. 90
11.3.1.1 U.K. project to sequence 100,000 genomes 90
11.3.1.2 Government funding in the U.K. 90
11.3.2 GERMANY 92
11.3.2.1 Conferences in Germany 92
11.3.3 FRANCE 94
11.3.3.1 Introduction of non-invasive prenatal testing in France 94
11.3.4 REST OF EUROPE (ROE) 96
11.3.4.1 Turkey to offer growth opportunities 96
11.3.4.2 Focus on Gene Therapy 96
11.3.4.3 Increasing funding for molecular diagnostics in Europe 96
11.3.4.4 Investments in rare disease research 97
11.4 ASIA PACIFIC 99
11.4.1 CHINA 101
11.4.1.1 Western partnerships in China aimed at improving healthcare 101
11.4.1.2 Domestic manufacturing of sequencing systems in China 102
11.4.1.3 Efforts of BGI to boost the Chinese market for gene expression 102
11.4.1.4 Gene expression signature for quality control of traditional Chinese medicines 102
11.4.2 JAPAN 104
11.4.2.1 Japanese government's focus on cancer 104
11.4.2.2 Research efforts in Japan 104
11.4.3 KOREA, AUSTRALIA, AND NEW ZEALAND 106
11.4.3.1 Need to develop treatments for animals 106
11.4.3.2 Flourishing bioresearch centers and financial support in Australia 106
11.4.4 REST OF ASIA-PACIFIC (ROAPAC) 108
11.4.4.1 Gene expression tests gaining popularity in India 108
11.4.4.2 The rise of the Indian gene expression analysis market 108
11.4.4.3 Regular funding from the Indian government, an impetus to the NGS market 109
11.4.4.4 Singapore's strong focus on neurodegenerative diseases 109
11.5 REST OF THE WORLD (ROW) 111
11.5.1.1 Sequencing of 100,000 Genomes in the Saudi Arabia 112
11.5.1.2 Focus on HIV/AIDS genetic research in Africa 112
11.5.1.3 South American countries focus on genomic research to improve public health 112
11.5.1.4 Bioinformatics and biotechnology research in Latin America to boost the demand for NGS instruments and services 112

12 COMPETITIVE LANDSCAPE 115
12.1 OVERVIEW 115
12.2 MARKET SHARE ANALYSIS 116
12.2.1 THERMO FISHER SCIENTIFIC 116
12.2.2 ILLUMINA, INC. 116
12.2.3 BIO-RAD LABORATORIES 117
12.2.4 QIAGEN N.V. 117
12.3 COMPETITIVE SITUATION AND TRENDS 118
12.3.1 NEW PRODUCT LAUNCHES 118
12.3.2 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS 119
12.3.3 ACQUISITIONS 120
12.3.4 OTHER STRATEGIES 121
13 COMPANY PROFILES 122
13.1 INTRODUCTION 122
13.2 THERMO FISHER SCIENTIFIC, INC. 123
13.3 QIAGEN N.V. 126
13.4 ILLUMINA, INC. 130
13.5 BIO-RAD LABORATORIES, INC. 135
13.6 F. HOFFMANN-LA ROCHE LTD. (ROCHE) 139
13.7 AGILENT TECHNOLOGIES, INC. 142
13.8 AFFYMETRIX, INC. 146
13.9 GE HEALTHCARE 150
13.10 PERKINELMER, INC. 153
13.11 OXFORD GENE TECHNOLOGY 155
*Details On Financials, Products and Services, Key Strategy, and Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
14 APPENDIX 157
14.1 DISCUSSION GUIDE 157
14.2 COMPANY DEVELOPMENTS (2013-2015) 161
14.2.1 THERMO FISHER SCIENTIFIC, INC. 161
14.2.2 QIAGEN N.V. 162
14.2.3 ILLUMINA INC. 163
14.2.4 ROCHE 166
14.2.5 BIO-RAD LABORATORIES 167
14.2.6 AGILENT TECHNOLOGIES, INC. 168
14.2.7 AFFYMETRIX 170
14.2.8 GE HEALTHCARE 171
14.2.9 PERKINELMER, INC. 171
14.2.10 OXFORD GENE TECHNOLOGY 172

14.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 173
14.4 AVAILABLE CUSTOMIZATIONS 173
14.5 RELATED REPORTS 174

LIST OF TABLES

TABLE 1 THE DECREASING COST OF SEQUENCING WILL ACT AS A MAJOR DRIVER FOR THE MARKET 46
TABLE 2 HIGH COST OF INSTRUMENTS IS A MAJOR FACTOR RESTRAINING MARKET GROWTH 47
TABLE 3 EMERGING COUNTRIES TO PROVIDE GROWTH OPPORTUNITIES FOR MARKET PLAYERS 49
TABLE 4 CURRENCY DEVALUATION POSES AS A CHALLENGE FOR THE MARKET GROWTH 50
TABLE 5 GENE EXPRESSION ANALYSIS MARKET SIZE, BY CONSUMABLES,
2013-2020 (USD MILLION) 52
TABLE 6 GENE EXPRESSION ANALYSIS CONSUMABLES MARKET SIZE, BY REGION,
2013-2020 (USD) MILLION 53
TABLE 7 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE, BY CONSUMABLES, 2013-2020 (USD MILLION) 53
TABLE 8 EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE, BY CONSUMABLES,
2013-2020 (USD MILLION) 53
TABLE 9 ASIA-PACIFIC: GENE EXPRESSION ANALYSIS MARKET SIZE, BY CONSUMABLES, 2013-2020 (USD MILLION) 54
TABLE 10 ROW: GENE EXPRESSION ANALYSIS MARKET SIZE, BY CONSUMABLES,
2013-2020 (USD MILLION) 54
TABLE 11 GENE EXPRESSION ANALYSIS REAGENTS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 55
TABLE 12 GENE EXPRESSION ANALYSIS DNA CHIPS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 56
TABLE 13 GENE EXPRESSION ANALYSIS DNA CHIPS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 56
TABLE 14 GENE EXPRESSION ANALYSIS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 58
TABLE 15 GENE EXPRESSION ANALYSIS TECHNOLOGIES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 59
TABLE 16 GENE EXPRESSION ANALYSIS MARKET SIZE FOR PCR, BY REGION,
2013-2020 (USD MILLION) 60
TABLE 17 GENE EXPRESSION ANALYSIS MARKET SIZE FOR NGS, BY REGION,
2013-2020 (USD MILLION) 61
TABLE 18 GENE EXPRESSION ANALYSIS MARKET SIZE FOR DNA MICROARRAY, BY REGION, 2013-2020 (USD MILLION) 63
TABLE 19 OTHER GENE EXPRESSION ANALYSIS TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 64
TABLE 20 GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 66
TABLE 21 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION,
2013-2020 (USD MILLION) 67
TABLE 22 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 67
TABLE 23 EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 67
TABLE 24 ASIA-PACIFIC: GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 68
TABLE 25 ROW: GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 68
TABLE 26 GENE EXPRESSION PROFILING SERVICES MARKET, BY REGION,
2013-2020 (USD MILLION) 69
TABLE 27 GENE EXPRESSION PROFILING SERVICES MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 69
TABLE 28 SEQUENCING SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 70
TABLE 29 OTHER SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 71
TABLE 30 BIOINFORMATICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 71
TABLE 31 GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 73
TABLE 32 GENE EXPRESSION ANALYSIS APPLICATIONS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 74
TABLE 33 GENE EXPRESSION ANALYSIS MARKET SIZE FOR RESEARCH APPLICATIONS,
BY REGION, 2013-2020 (USD MILLION) 75
TABLE 34 GENE EXPRESSION ANALYSIS MARKET SIZE FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2013-2020 (USD MILLION) 75
TABLE 35 GENE EXPRESSION ANALYSIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS,
BY REGION, 2013-2020 (USD MILLION) 76
TABLE 36 GENE EXPRESSION ANALYSIS MARKET SIZE FOR OTHER APPLICATIONS,
BY REGION, 2013-2020 (USD MILLION) 77
TABLE 37 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION) 81
TABLE 38 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION) 81
TABLE 39 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES,
BY TYPE, 2013-2020 (USD MILLION) 81
TABLE 40 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 82
TABLE 41 U.S.: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 84
TABLE 42 U.S.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES,
BY TYPE, 2013-2020 (USD MILLION) 84
TABLE 43 U.S.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS,
BY TYPE, 2013-2020 (USD MILLION) 84
TABLE 44 U.S.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE,
2013-2020 (USD MILLION) 85
TABLE 45 CANADA: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 86
TABLE 46 CANADA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES,
BY TYPE, 2013-2020 (USD MILLION) 86
TABLE 47 CANADA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS,
BY TYPE, 2013-2020 (USD MILLION) 87
TABLE 48 CANADA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES,
BY TYPE, 2013-2020 (USD MILLION) 87
TABLE 49 EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES,
BY TYPE, 2013-2020 (USD MILLION) 89
TABLE 50 EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS,
BY TYPE, 2013-2020 (USD MILLION) 89
TABLE 51 EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION) 89
TABLE 52 EUROPE: GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 90
TABLE 53 U.K.: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 91
TABLE 54 U.K.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION) 91
TABLE 55 U.K.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION) 91
TABLE 56 U.K.: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE,
2013-2020 (USD MILLION) 92
TABLE 57 GERMANY: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 92
TABLE 58 GERMANY: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES,
BY TYPE, 2013-2020 (USD MILLION) 93
TABLE 59 GERMANY: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS,
BY TYPE, 2013-2020 (USD MILLION) 93
TABLE 60 GERMANY: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES,
BY TYPE, 2013-2020 (USD MILLION) 93
TABLE 61 FRANCE: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 94
TABLE 62 FRANCE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES,
BY TYPE, 2013-2020 (USD MILLION) 94
TABLE 63 FRANCE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS,
BY TYPE, 2013-2020 (USD MILLION) 95
TABLE 64 FRANCE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION) 95
TABLE 65 ROE: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 97
TABLE 66 ROE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION) 97
TABLE 67 ROE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION) 98
TABLE 68 ROE: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE,
2013-2020 (USD MILLION) 98
TABLE 69 APAC: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION) 100
TABLE 70 APAC: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION) 100
TABLE 71 APAC: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE,
2013-2020 (USD MILLION) 100
TABLE 72 APAC: GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 101
TABLE 73 CHINA: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 103
TABLE 74 CHINA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION) 103
TABLE 75 CHINA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION) 103
TABLE 76 CHINA: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION) 104
TABLE 77 JAPAN: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 105
TABLE 78 JAPAN: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION) 105
TABLE 79 JAPAN: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION) 105
TABLE 80 JAPAN: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION) 106
TABLE 81 KANZ: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 107
TABLE 82 KANZ: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION) 107
TABLE 83 KANZ: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION) 107
TABLE 84 KANZ GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE,
2013-2020 (USD MILLION) 108
TABLE 85 ROAPAC: GENE EXPRESSION ANALYSIS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 109
TABLE 86 ROAPAC: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES,
BY TYPE, 2013-2020 (USD MILLION) 110
TABLE 87 ROAPAC: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS,
BY TYPE, 2013-2020 (USD MILLION) 110
TABLE 88 ROAPAC GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE, 2013-2020 (USD MILLION) 110
TABLE 89 ROW: GENE EXPRESSION ANALYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION) 113
TABLE 90 ROW: GENE EXPRESSION ANALYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION) 113
TABLE 91 ROW: GENE EXPRESSION ANALYSIS MARKET SIZE FOR SERVICES, BY TYPE,
2013-2020 (USD MILLION) 113
TABLE 92 ROW: GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 114
TABLE 93 NEW PRODUCT LAUNCHES, 2012-2015 118
TABLE 94 COLLABORATIONS, AGREEMENTS, PARTNERSHIPS, 2012-2015 119
TABLE 95 ACQUISITIONS, 2012-2015 120
TABLE 96 OTHER STRATEGIES, 2012-2015 121
LIST OF FIGURES

FIGURE 1 GLOBAL GENE EXPRESSION ANALYSIS MARKET: RESEARCH METHODOLOGY STEPS 21
FIGURE 2 SAMPLING FRAME: PRIMARY RESEARCH 24
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 25
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 27
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 27
FIGURE 6 RESEARCH DESIGN 28
FIGURE 7 DATA TRIANGULATION METHODOLOGY 29
FIGURE 8 GENE EXPRESSION ANALYSIS MARKET SIZE, BY PRODUCTS and SERVICES,
2015 VS. 2020 (USD MILLION) 30
FIGURE 9 GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2015 VS. 2020 (USD MILLION) 31
FIGURE 10 GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION,
2015 VS. 2020 (USD MILLION) 32
FIGURE 11 GENE EXPRESSION ANALYSIS MARKET SIZE, BY REGION,
2015 VS. 2020 (USD MILLION) 33
FIGURE 12 STRONG FOCUS ON RESEARCH and DECREASING COST OF SEQUENCING—MAJOR DRIVERS FOR THE GENE EXPRESSION ANALYSIS MARKET 35
FIGURE 13 NORTH AMERICA AND RESEARCH SEGMENT DOMINATES THE GENE EXPRESSION ANALYSIS MARKET IN 2015 36
FIGURE 14 ASIA-PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 37
FIGURE 15 NGS SEGMENT TO GROW AT THE HIGHEST CAGR FROM 2015 TO 2020 38
FIGURE 16 VALUE CHAIN FOR SEQUENCING PLATFORMS 39
FIGURE 17 PORTER'S FIVE FORCES ANALYSIS 40
FIGURE 18 GENE EXPRESSION ANALYSIS: MARKET SEGMENTATION 43
FIGURE 19 GENE EXPRESSION ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE 44
FIGURE 20 BIOCON LTD.: ANNUAL REVENUES, 2010-2014 (USD MILLION) 48
FIGURE 21 REAGENTS DOMINATE THE GENE EXPRESSION CONSUMABLES MARKET 52
FIGURE 22 PCR SEGMENT IS EXPECTED TO DOMINATE THE MARKET IN 2015 58
FIGURE 23 GENE EXPRESSION PROFILING SERVICES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 66
FIGURE 24 RESEARCH SEGMENT TO DOMINATE THE GENE EXPRESSION ANALYSIS MARKET
IN 2015 73
FIGURE 25 NORTH AMERICA DOMINATES THE GLOBAL GENE EXPRESSION ANALYSIS MARKET IN 2015 79
FIGURE 26 U.S. HOLDS HIGHEST SHARE OF THE NORTH AMERICAN GENE EXPRESSION ANALYSIS MARKET IN 2015 80
FIGURE 27 U.K. HOLDS LARGEST SHARE OF THE EUROPEAN MARKET FOR GENE EXPRESSION ANALYSIS 88
FIGURE 28 CHINA IS EXPECTED TO DOMINATE THE ASIA-PACIFIC MARKET 99
FIGURE 29 ROW REGION IS EXPECTED TO WITNESS SLOW GROWTH IN THE GENE EXPRESSION ANALYSIS MARKET 111
FIGURE 30 NEW PRODUCT LAUNCH WAS THE MAJOR GROWTH STRATEGY ADOPTED BY MARKET PLAYERS 115
FIGURE 31 GLOBAL GENE EXPRESSION ANALYSIS MARKET SHARE, BY KEY PLAYER, 2014 116
FIGURE 32 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY (2012-2015) 118
FIGURE 33 GEOGRAPHIC REVENUE MIX OF THE MAJOR PLAYERS 122
FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 123
FIGURE 35 QIAGEN N.V.: COMPANY SNAPSHOT 126
FIGURE 36 ILLUMINA, INC.: COMPANY SNAPSHOT 130
FIGURE 37 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 139
FIGURE 38 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 135
FIGURE 39 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 142
FIGURE 40 AFFYMETRIX, INC.: COMPANY SNAPSHOT 146
FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT 150
FIGURE 42 PERKINELMER, INC.: COMPANY SNAPSHOT 153

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global and Chinese Gene Expression Industry, 2016 Market Research Report

Global and Chinese Gene Expression Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Gene Expression Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Gene Expression industry with a focus on ...

Global Microarray Market 2016-2020

Global Microarray Market 2016-2020

  • $ 2500
  • Industry report
  • November 2016
  • by Infiniti Research Limited

About Microarray A microarray is an advanced tool used in molecular biology. It allows end-users to conduct high-throughput and highly parallel analyses of more than thousand points of interest that include ...

VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2016

VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.